BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30972541)

  • 1. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
    La Jeon Y; Kang SY; Lee WI; Kim MH
    Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
    Türkoğlu G; Berkem R; Karakoç AE
    Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
    Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
    J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
    Yumuk Z; Demir M
    J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.
    Lee H; Kim Y; Han K; Oh EJ
    Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies].
    Çetin Duran A; Barut K; Duran A; Eren Dağlar D
    Mikrobiyol Bul; 2021 Jul; 55(3):415-425. PubMed ID: 34416806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA; Bauer O; Seelig HP
    Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
    Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
    Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.
    Shovman O; Gilburd B; Chayat C; Amital H; Langevitz P; Watad A; Guy A; Perez D; Azoulay D; Blank M; Segal Y; Bentow C; Mahler M; Shoenfeld Y
    Clin Exp Rheumatol; 2018; 36(1):121-126. PubMed ID: 28770702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.
    Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M
    Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
    Mahler M; Hanly JG; Fritzler MJ
    Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence.
    Bizzaro N; Tonutti E; Tampoia M; Infantino M; Cucchiaro F; Pesente F; Morozzi G; Fabris M; Villalta D;
    Clin Chim Acta; 2015 Dec; 451(Pt B):271-7. PubMed ID: 26471835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
    Peker BO; Şener AG; Tarhan EF; Kaya S
    Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Relevance of Anti-DFS70 Autoantibodies.
    Conrad K; Röber N; Andrade LE; Mahler M
    Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
    Seelig CA; Blüthner M; Seelig HP
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern.
    Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E
    J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A better definition of the anti-DFS70 antibody screening by IIF methods.
    Infantino M; Shovman O; Pérez D; Grossi V; Manfredi M; Benucci M; Damiani A; Gilburd B; Azoulay D; Serrano A; Shoenfeld Y
    J Immunol Methods; 2018 Oct; 461():110-116. PubMed ID: 30017652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
    Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
    Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.